Антифосфолипидный синдром - Насонов Е.Л.
ISBN 5-98216-010-5
Скачать (прямая ссылка):
69. Sebastiani GD, Galeazzi M, Tincani A, et al. Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE. Scand J Rheumatol 1999; 28: 344.
70. Nasonov EL, Kovalev VYu, Alekberova ZS, Soloviev SK. Prediction of thrombosis in patients with systemic lupus erythematosus: the role of antibodies to cardiolipin. Sov Arch Intern Med 1992; 64: 348—353.
71. Neville C, Rauch J, Kassis J, et al. Thrombotic risk in partients with high titre anti-cardiolipin and multiple antibodies. Thromb Haemost 2003; 90: 108.
72. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immu-nologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019.
73. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulant are stronger risk factor for thrombosis than anticatdiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827—1832.
SHS-OOO4.qxd 21.11.2006 16:56 Page 246"
Насонов Е.Л. Антифосфолипидный синдром.
74. Александрова ЕН, Новиков АА, Решетняк ТМ, Клюквина НГ, Решетняк ДВ, Насонов Е.Л. Антитела к ?2-Tn1 и антитела к кардиолипину при антифосфолипидном синдроме: анализ чувствительности и специфичности. Клин. медицина, 2003; 9: 25—31.
75. Amengual O, Atsumi T, Khamashta MA, Koike T, Huges GRV. Specificity of ELISA for antibody to ?2-glicoprotein I in patients with antiphospholipid sindrome. Br J Rheumatol 1996; 35: 1239—1243.
76. Carreras LO, Forastiero RR, Martinuzzo ME. Which are the best biological markers of the antiphospholipid syndrome? J Autoimmunity 2000; 15: 163—172.
77. Решетняк ТМ, Дерксен РВ, Алекберова ЗС, и др. Антитела к ?2-гликопртеину I при системной красной волчанке: новый лаборо-торный маркер антифосфолипидного синдрома. Клин. медицина, 1998; 3: 36—40.
78. Martinuzzo ME, Forastiero RR, Carreras LO. Anti ?2-glycoprotein I antibodies: detection and association with trombosis Br J Haematol 1995; 89: 397—405.
79. Gomez-Pacheco L, Villa AR, Drencard C, Cabiedes J, Cabral AR, Alarcon-Segovia D. Serum anti- 2-glycoprotein I and anticardiolipin antibodies during trombosis in systemic lupus ery-tematosus patients. Am J Med 1999; 106: 417— 423.
80. Long AA, Ginsberg JS, Brill-Edwards P, Johnston M, Turner C, Deuburg JA, Bensen WG, Cividino A, Andrew M, Hirsh J. The realation-ship of antiphospholipid antibodies to throm-boembolic disease in systemic lupus erytematosus: a cross-sectional study. Thromb Haemost 1991; 66: 520—525.
81. Wahl DG, Guillemin F, de Maistre E, Peret C., Lecompte T, Thibaut G. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus-A meta-analisis. Lupus 1997; 6: 464—473.
82. Roubey RAS, Maldonado MA, Byrd SN. Comparison of an enzimelinked immunosorbent assay for antibodies to ?2-glycoprotein I and a conventional anticardiolipin immunoassay. Arthritis Rheum 1996; 39: 1606—1607.
83. Detkova D, Gil-Aguado A, Lavilla P et al. Do antibodies to ?2-glycoprotein I contribute to
the better characterization of the antiphospholipid syndrome?Lupus 1999; 8: 430-438.
84. Harris EN, Pierangeli SS, Gharavi AE. Diagnosis of the antiphospholipid syndrome a proposal for use of laboratory tests. Lupus 1998; 7(Suppl); S.144—148.
85. Najmey SS, Keil B, Adib DY, De Bary VA. The association of antibodies to ?2-glicoprotein I with the antiphospholipid syndrome: A Meta-analysis. Ann Clin Lab Science 1997; 27: 41—46
86. Cabiedes J, Cabral A, Alarcon-Segovia D. Clinical manifestation of the antiphospholipid syndrome in patients with systemic lupus erytem-atosus associate more strongly with anti-? 2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899—1906.
87. Picillo U, Marcilis MR, Italiano G. Antibodies to ?2-glycoprotein I in anticardiolipin negative patients. J Rheumatol 1998; 25: 1440— 1442.
88. Loizou S, Byron MA, Englert HJ, et al. Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Q J Med 1988; 68:525
89. Geis W, Branch DW. Obstetric implications of antiphospholipid antibodies: pregnancy loss and other complications. Clin Obstet Gynecol 2001; 44: 2.
90. Lockwood CJ, Schur PH. Clinical manifestations and diagnosis of the antiphospholipid syndrome in pregnancy UpToDate 2003; 11.3.
91. Oshiro BT, Silver RM, Scott JR, et al. Antiphospholipid antibodies and fetal death. Obstet Gynecol 1996; 87: 489.
92. Kupferminc MJ. Thrombophilia and pregnancy. Reproductive Biol Endocrinol 2003; 1: 111.
93. Branch DW, Scott JR, Kochenour NK, et al. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313: 1322.
94. Branch DW, Khamashta MA. Antiphos-pholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 2003; 101: 1333.
